{
    "2021-03-04": [
        [
            {
                "time": "2021-03-04",
                "original_text": "国产PD-1单抗“出海”加速：一药物在美国提交上市申请",
                "features": {
                    "keywords": [
                        "国产PD-1",
                        "单抗",
                        "出海",
                        "美国",
                        "上市申请"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "【瞩目】$15亿重磅首仿，“研发一哥”获批了",
                "features": {
                    "keywords": [
                        "首仿",
                        "研发一哥",
                        "获批"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "隐秘的减持之手，大宗交易异动透视股东动向",
                "features": {
                    "keywords": [
                        "减持",
                        "大宗交易",
                        "股东动向"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "每日“药”闻|KemPharm多动症口服药获批上市；中和抗体疗法迎变数，Vir股价大跌",
                "features": {
                    "keywords": [
                        "KemPharm",
                        "多动症口服药",
                        "中和抗体疗法",
                        "Vir股价",
                        "大跌"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "Wind医药：每日行业动态（2021-03-04）",
                "features": {
                    "keywords": [
                        "Wind医药",
                        "行业动态"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "生物药“集采禁区”被打破，格局重构谁是最大赢家？",
                "features": {
                    "keywords": [
                        "生物药",
                        "集采禁区",
                        "格局重构"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-03",
                "original_text": "A股融资融券日报：两融余额增加31.85亿元（3月3日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "北向资金扫货A股90亿，超一半资金买入这一板块，却出逃格力、茅台",
                "features": {
                    "keywords": [
                        "北向资金",
                        "扫货",
                        "A股",
                        "格力",
                        "茅台"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "私募机构：部分白马股迎来左侧交易窗口",
                "features": {
                    "keywords": [
                        "私募机构",
                        "白马股",
                        "左侧交易"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}